Article ; Online: Tranylcypromin bei chronifizierter therapieresistenter Agoraphobie mit Panikstörung und rezidivierender depressiver Störung.
2010 Volume 37, Issue 7, Page(s) 350–352
Abstract: Objective: Tranylcypromine has been recommend as an option for therapy-resistant depressive and anxiety disorders. In this case report the effectiveness of this medication as a part of a combined therapy-program including pharmacological, behavioural ... ...
Title translation | Tranylcypromine for chronic therapy-resistant agoraphobia with panic disorder and recurrent depressive disorder. |
---|---|
Abstract | Objective: Tranylcypromine has been recommend as an option for therapy-resistant depressive and anxiety disorders. In this case report the effectiveness of this medication as a part of a combined therapy-program including pharmacological, behavioural and psychodynamic interventions could be demonstrated on an outpatient with a therapy-resistant depression and agoraphobia. Methods: The development of the illness, clinical symptoms and the 4 year ongoing therapy of a 69-year old patient are described in detail. Results/conclusion: After the failure of 13 antidepressant agents with considerable side effects, a one year sustained remission of depression as well as great improvement of agoraphobia could be achieved with tranylcypromine. In this situation, tranylcypromine showed itself, for the first time, to be a very effective and well tolerated antidepressant. |
MeSH term(s) | Aged ; Agoraphobia/diagnosis ; Agoraphobia/drug therapy ; Agoraphobia/psychology ; Ambulatory Care ; Anti-Anxiety Agents/therapeutic use ; Antidepressive Agents/therapeutic use ; Cognitive Therapy ; Combined Modality Therapy ; Comorbidity ; Depressive Disorder, Major/diagnosis ; Depressive Disorder, Major/drug therapy ; Depressive Disorder, Major/psychology ; Drug Resistance ; Follow-Up Studies ; Humans ; Implosive Therapy ; Male ; Panic Disorder/diagnosis ; Panic Disorder/drug therapy ; Panic Disorder/psychology ; Patient Readmission ; Psychoanalytic Therapy ; Tranylcypromine/therapeutic use ; Treatment Outcome |
Chemical Substances | Anti-Anxiety Agents ; Antidepressive Agents ; Tranylcypromine (3E3V44J4Z9) |
Language | German |
Publishing date | 2010-10 |
Publishing country | Germany |
Document type | Case Reports ; English Abstract ; Journal Article |
ZDB-ID | 124981-2 |
ISSN | 1439-0876 ; 0303-4259 |
ISSN (online) | 1439-0876 |
ISSN | 0303-4259 |
DOI | 10.1055/s-0030-1248499 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 971: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.